(Q46928445)

English

Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).

scientific article published on 20 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012). (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

Gram-negative bacteria

0 references

urinary tract infection

1 reference

based on heuristic

inferred from title

3

object named as

Helio S Sader

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

1

object named as

Robert K Flamm

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

4

object named as

Ronald N Jones

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

author name string

David J Farrell

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

language of work or name

0 references

publication date

20 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

69

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

1589-1598

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized stud

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

The perpetual challenge of infectious diseases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Nosocomial bloodstream infections: organisms, risk factors, and implications

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

A Comprehensive review of abdominal infections.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Combating antimicrobial resistance: policy recommendations to save lives

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Identifiers

10.1093/JAC/DKU025

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24562613

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46928445&oldid=1940470267"